BNIGF Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.82
Previous CloseN/A
Volume1.00
Average Volume (3M)49.00
Market Cap
$53.05M
Enterprise ValueN/A
Total Cash (Recent Filing)$2.38M
Total Debt (Recent Filing)$1.44M
Price to Earnings (P/E)―
Beta-0.06
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding33,987,280
10 Day Avg. Volume148
30 Day Avg. Volume49
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BNIGF FAQ
What was Beroni Group’s price range in the past 12 months?
Beroni Group lowest stock price was <$0.01 and its highest was $0.82 in the past 12 months.
What is Beroni Group’s market cap?
Beroni Group’s market cap is $53.05M.
When is Beroni Group’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Beroni Group’s earnings last quarter?
Currently, no data Available
Is Beroni Group overvalued?
According to Wall Street analysts Beroni Group’s price is currently Overvalued.
Does Beroni Group pay dividends?
Beroni Group does not currently pay dividends.
What is Beroni Group’s EPS estimate?
Beroni Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beroni Group have?
Beroni Group has 33,987,280 shares outstanding.
What happened to Beroni Group’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Beroni Group?
Currently, no hedge funds are holding shares in BNIGF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Beroni Group
Beroni Group is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of FDA/CE approved virus diagnostic kits, an e-commerce platform for the sale of pharmaceutical products, and a development pipeline targeting oncology and cell therapies. The company has operations in Australia, the United States, China, and Japan.